Emerging drugs for autonomic dysfunction in Parkinson's disease.
about
Salivary Secretory Disorders, Inducing Drugs, and Clinical ManagementDeficits in cholinergic neurotransmission and their clinical correlates in Parkinson's disease.Gastrointestinal Dysfunctions in Parkinson's Disease: Symptoms and Treatments.A review of lower urinary tract symptoms in patients with Parkinson's disease.Management of constipation in Parkinson's disease.A guideline for the management of bladder dysfunction in Parkinson's disease and other gait disorders.Management of lower urinary tract symptoms in Parkinson's disease in the neurology clinic.Saliva α-Synuclein and A High Extinction Coefficient Protein: A Novel Approach in Assessment Biomarkers of Parkinson's Disease.
P2860
Q26777907-E56120EA-05DD-428C-9522-83487AA9A459Q33917311-FE8A0728-C492-4A30-B50F-EBAE84CFAFCCQ37516494-8191018A-1810-451C-BBFF-B37998AD4860Q38227099-77F17B05-F48C-4D53-8ECD-2D8A30DC7943Q38300388-B76862D6-5225-4092-9926-45905B8F4BC1Q38391474-4BEFF8BF-8618-4FEB-B00F-E58AD43C7180Q38800103-34156D9E-C6D2-4627-BD63-6D7B4DDE9D0CQ41963683-3B5C8468-D282-4E88-BE74-D3716C934C1A
P2860
Emerging drugs for autonomic dysfunction in Parkinson's disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Emerging drugs for autonomic dysfunction in Parkinson's disease.
@en
type
label
Emerging drugs for autonomic dysfunction in Parkinson's disease.
@en
prefLabel
Emerging drugs for autonomic dysfunction in Parkinson's disease.
@en
P2093
P2860
P1476
Emerging drugs for autonomic dysfunction in Parkinson's disease.
@en
P2093
Anne Pavy-Le Traon
María Verónica Rey
Santiago Perez-Lloret
P2860
P356
10.1517/14728214.2013.766168
P407
P577
2013-02-01T00:00:00Z